China suspends three Brazilian beef plants over banned residue

China has temporarily suspended imports from three Brazilian slaughterhouses after detecting residues of a banned synthetic hormone.

China’s General Administration of Customs identified residues of acetato de medroxiprogesterona in shipments from JBS’s plant in Pontes e Lacerda (MT), PrimaFoods’s facility in Araguari (MG) and Vale Grande Indústria e Comércio de Alimentos, operating as Frialto, in Matupá (MT).

Abiec stated that the suspension is temporary and preventive to allow traceability of raw materials and technical measures by the companies and authorities. The association noted that the issue is under technical discussion between Brazil and China for swift normalization.

The action follows the recent clearance of three other Brazilian plants, including a JBS unit in Mozarlândia (GO). Sixty-three Brazilian facilities are currently authorized to export beef to China, the main destination for the product.

関連記事

Agribusiness leaders at Expozebu criticize end of 6x1 work scale, with ABCZ president speaking to concerned crowd amid zebu cattle.
AIによって生成された画像

Agribusiness criticizes end of 6x1 scale at Expozebu opening

AIによるレポート AIによって生成された画像

Agribusiness leaders gathered at the Expozebu opening in Uberaba, Minas Gerais, on Saturday (25), criticized President Luiz Inácio Lula da Silva's government proposal to end the 6x1 work scale. The ABCZ president urged lawmakers to vote against it, highlighting risks to the sector's economy.

中国はドナルド・トランプ米大統領の訪中および習近平国家主席との会談に合わせ、数百の米国産牛肉加工施設の輸入許可を更新した。ブラジルの対中牛肉輸出は年間割当枠に迫っており、代替市場の模索を急いでいる。

AIによるレポート

The European Union removed Brazil from its list of countries compliant with sanitary rules on antibiotic use in livestock. The measure, effective from September, could cost the country nearly US$ 2 billion in annual meat sales.

A report from Argentina's Observatorio de la Cadena Láctea Argentina warns that China, the world's top dairy buyer, has reduced import volumes by up to 16.5% at the start of 2026. Prices in dollars are cushioning the decline while domestic production rises.

AIによるレポート

Brazil's Fiocruz, through its Farmanguinhos unit, has begun fully domestic production of tacrolimus, an immunosuppressant to prevent organ transplant rejection. The milestone stems from a Product Development Partnership (PDP) with Brazilian firm Libbs, which acquired manufacturing technology from India's Biocon. Farmanguinhos now becomes the sole supplier to the SUS public health system.

このウェブサイトはCookieを使用します

サイトを改善するための分析にCookieを使用します。詳細については、プライバシーポリシーをお読みください。
拒否